all the information, none of the junk | biotech • healthcare • life sciences

Synlogic Taps Andrew Gengos for Chief Operating Officer Post

Andrew Gengos has been named chief operating officer and head of corporate development for Cambridge, MA, biotech Synlogic (NASDAQ: SYBX). Gengos was most recently president and CEO of Westlake Village, CA-based ImmunoCellular Therapeutics (NYSE MKT: IMUC). Synlogic, which genetically engineers microbes for therapeutic applications, went public earlier this year in a reverse merger.

Frank Vinluan is editor of Xconomy Raleigh-Durham, based in Research Triangle Park. You can reach him at fvinluan [at] xconomy.com Follow @frankvinluan